Skip to content

Clinical trials

COVID-19 trials in Chile

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: COVID-19 Country / region: Chile Clear all

54 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
202031
202117
20223
20233

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed34
Unknown status12
Terminated7
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pontificia Universidad Catolica de Chile13
University of Chile8
AstraZeneca2
CanSino Biologics Inc.2
Merck Sharp & Dohme LLC2
Universidad Nacional Andres Bello2
Universidad de Magallanes2
Universidad del Desarrollo2
Amgen1
Boehringer Ingelheim1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
COVID-1954
Anxiety Disorders4
Coronavirus Infections4
Severe Acute Respiratory Syndrome3
Critical Illness2
Respiratory Aspiration2
Acute Lung Injury1
Ataxia1
Cognition Disorders1
Cognitive Dysfunction1

Trials

Showing 26 to 50 of 54. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.